Manchester Molecular Pathology Innovation Centre (MMPathIC) has developed a virtual pipeline model for the development of novel biomarkers and technologies; offering a simplified and streamlined pathway for market access.
Cemsel Bafligil, NIHR Manchester BRC PhD student blogs about her experience of the NIHR Infrastructure Doctoral Training Camp that took place in July.
Researchers from NIHR Manchester Biomedical Research Centre have identified a new mechanism which switches off a gene in families affected by breast and ovarian cancer.
An opportunity to discuss and develop understanding around risk factors influencing disease occurrence and re-occurrence.
Ellena Badrick, Cancer Data Scientist, blogs about her research, where she is looking at how working with large data cohorts can help improve early cancer detection.
On 1st June the BRC’s Cancer Prevention and Early Detection (PED) Theme held a research showcase open to researchers and collaborative partners to celebrate a successful first year of funding.
The Manchester BRC and CRF have been chosen as one of 13 centres around England which will contribute to the new NIHR BioResource for Translational Research in Common and Rare Diseases.
The Public Programmes Team are running free Patient and Public Involvement (PPI) advice sessions for BRC and CRF researchers working in the areas of cancer, dermatology and musculoskeletal research.